Details of the Drug Reposition

General Information of This Drug (ID: DM45OJN)

• Drug Name: Mometasone (DM45OJN)
• Synonyms: Elocom; Mometasona; Mometasonum; Mometasona [Spanish]; Mometasonum [Latin]; Asmanex (TN); Elocon (TN); Mometasone (INN); Nasonex (TN); Twisthaler (TN); (+)-Mometasone; (8S,9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloroacetyl)-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one; (9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloroacetyl)-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one; 9,21-dichloro-11beta,17-dihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione
• Therapeutic Class: Antiinflammatory Agents
• Drug Type: Small molecular drug

Information on Drug Reposition of This Drug

7 Approved Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Primary cutaneous T-cell lymphoma	DIS35WVW	N.A.	Approved	[1]
Intrinsic asthma	DIS2U1Q9	N.A.	Approved	[1]
Granuloma annulare	DISMOUMI	N.A.	Approved	[1]
Exanthem	DISAFOQN	N.A.	Approved	[1]
Skin allergy	DISHN726	4A82	Approved	[2]
Allergic rhinitis	DIS3U9HN	CA08.0	Approved	[1]
Allergic asthma	DISHF0H3	CA23.0	Approved	[1]

1 Discontinued in Phase 3 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Contact dermatitis	DISQ3AU0	EK0Z	Discontinued in Phase 3	[3]

1 Discontinued in Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Seborrhoeic dermatitis	DISNWVJU	EA81	Discontinued in Phase 2	[4]

1 Investigative Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Sinusitis	DISX5NCF	CA0A.Z	Investigative	[1]

References

• [1] Mometasone FDA Label
• [2] Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77.
• [3] Famvir for Treatment of Hearing in Unilateral Meniere's Disease
• [4] Sunitinib in Treating Patients With Idiopathic Myelofibrosis